MarginsXMarginsX
Home › Markets › CETXP

Cemtrex Inc (CETXP)

CETXP is quoted over the counter, not listed on an exchange. Cemtrex Inc files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · November 9, 2026
$0.5500
No trades since Nov 9, 2026; later closes repeat the last quote
1-year return
+239.7%
Market cap
The company also trades on Nasdaq as CETX; this OTC line is another class or a foreign line, so its cap is not computed
P/E and P/S
Needs a market cap · Needs a market cap
On trailing twelve months to June 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerCETXP, quoted over the counter
SEC CIK0001435064
OTC Markets tierOTCID (price source, 2026-11-13)
SEC industry codeConstruction - Special Trade Contractors
Business addressBrooklyn, NY
Incorporated inDE

Warning signs

Cash runway
11.7 months
$8.0M cash at June 30, 2026
Share count, 1 year
+4446.7%
2025-08-12 to 2026-08-12 · +54306316.0% over 3 years
Going-concern doubt
Yes
10-Q filed August 14, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"The Company has incurred substantial net losses attributable to Cemtrex, Inc. stockholders of $ 28,112,368 and $ 7,229,491 for fiscal years 2025 and 2024, respectively and a net losses attributable to Cemtrex, Inc. stockholders of $ 24,175,509 for the nine months ended June 30, 2026, and has debt obligations over the next fiscal year of $ 10,448,709 that raise substantial doubt with respect to the Company's ability t"
10-Q 2026-08-14
Cash and burn$8.0M cash; operating cash flow -$2.0M a quarter.Report 2026-06-30
Shares outstanding1,721,141 (2026-08-12); 5,678,183 a year earlier; 998,334 three years earlier. 1y figure adjusted for splits (1-for-150 overall); 3y figure adjusted for splits (1-for-315000 overall).Cover page 2026-08-12
Reverse splits, 3 years4; latest 1-for-10 on 2026-06-05Source 2026-06-05
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 4 424B5 takedowns, 4 at the marketLatest 2026-01-09
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorGrassi & Co., CPAs, P.C., Jericho, New York, United StatesPCAOB Form AP 2026-01-05
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30
Market cap checkThe listing's market cap implies 3,172,233 shares at the 2026-11-13 price; the latest SEC cover count is 1,721,141 as of 2026-08-12. One of the two share counts is stale.Nasdaq screener and SEC cover page

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-06-30
$18.4M-$4.5M$410K$8.0M$16.6M$71.2M10-Q 2026-08-14
Q2 2026
2026-03-31
$18.1M$907K-$4.4M$6.6M$17.5M$69.7M10-Q 2026-05-15
Q1 2026
2025-12-31
$16.1M-$20.6M-$892K$20.5M$12.8M$78.9M10-Q 2026-02-17
Q4 2025
2025-09-30
$18.5M-$3.2M-$3.3M$5.0M$13.5M$76.5M10-K 2025-12-29
Q3 2025
2025-06-30
$17.0M-$4.6M$1.8M$7.0M$18.3M$76.1M10-Q 2026-08-14
Q2 2025
2025-03-31
$27.3M$8.6M$2.8M$4.5M$18.9M$73.8M10-Q 2026-05-15
Q1 2025
2024-12-31
$13.7M-$28.8M-$1.2M$4.2M$18.7M$63.7M10-Q 2026-02-17
Q4 2024
2024-09-30
$18.1M$4.4M-$1.9M$3.9M$18.0M$66.9M10-K 2025-12-29

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-01-09
Latest annual report10-K/A2026-01-16
Latest quarterly / interim10-Q2026-08-14
Latest current report8-K2026-10-09
Latest proxyDEF 14A2026-03-26

Source: SEC EDGAR submissions feed, 553 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier